Indikasjoner:Til behandling av typiske absenser (petit mal) og atypiske absenser, myokloniske anfall og atoniske anfall. Andrelinjebehandling av.
N06D X02 - Ginkgoblad Klinisk konsekvens Interaksjonsmekanisme Legemiddelalternativer Kildegrunnlag Kasusrapporter Kilder Klinisk konsekvens Interaksjonsmekanisme Dosetilpasning Monitorering Kildegrunnlag Interaksjonsstudier Kilder Klinisk konsekvens Interaksjonsmekanisme Dosetilpasning Monitorering Kildegrunnlag Interaksjonsstudier Kilder Etanol (96 %).
respirasjonsdepresjon : Svekket pustefunksjon, noe som gjør det vanskelig for kroppen å opprettholde oksygenkonsentrasjonen og å fjerne karbondioksid fra blodet.
A double-blind cross-over study with clonazepam (Rivotril) 0.5 mg b.i.d. versus placebo was carried out in 38 migraine patients. After a pre–test.
With regard to headache days, the results for both I and 2 mg Rivotril differed significantly (p<0.05) from the pre–test status, whereas with regard to the headache index, only the result for 2 mg differed significantly from pre-test results. When the placebo results (and not the pre–test results) were used, no significant difference was found with either 1 or 2 mg Rivotril.
Article first published online: 23 JUN 2005 DOI: 10.1111/j.. 1979.hed1906333.x Issue.
Dept. of Neurology, The National Hospital, University of Oslo, Oslo, Norway. SYNOPSIS.
More than half the patients complained of some drowsiness on Rivotril medication, particularly in the initial phase. Eighteen patients continued with Rivotril medication on a long–term basis in an open trial with some beneficial effect and less side–effects.
Stensrud, P. and Sjaastad, O. (1979), Clonazepam (Rivotril) in Migraine Prophylaxis. Headache: The Journal of Head and Face Pain, 19: 333–334. doi: 10.1111/j.. 1979.hed1906333.x.
Volume 19, Issue 6, pages 333–334, September 1979 Additional Information.
A double-blind cross-over study with clonazepam (Rivotril) 0.5 mg b.i.d. versus placebo was carried out in 38 migraine patients. After a pre–test period of 4 weeks, Rivotril 1 mg per day and placebo were given during a 4 week period each, in a randomized fashion; thereafter Rivotril 2 mg per day was given for 4 weeks in a semi-blind fashion.
Treatment with Rivotril in doses of 2-10 mg daily was given to 26 patients with various forms of epilepsy, mostly refractory to previous treatment. In 2 cases the.
National Center for Biotechnology Information, U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.
Treatment with Rivotril in doses of 2-10 mg daily was given to 26 patients with various forms of epilepsy, mostly refractory to previous treatment. In 2 cases the drug was withdrawn on account of intolerance, in 4 cases treatment was stopped after several days in view of greatly increased frequency of seizures. In the remaining cases the drug was administered during 2 to 27 months, (mean 7 months) in 3 cases as the only medication and in 17 with other anticonvulsants. The best therapeutic results were obtained in patients with partial seizures of complex symptomatology and in generalized non-convulsive seizures, the worst results in generalized seizures. Electroencephalographic findings included particularly disappearance of seizure activity, while focal changes persisted and even grew worse in some cases. Apart from 2 cases of acute intolerance in another 4 cases side effects were observed with somnolence, dizziness, equilibrium disturbances, and in one case granulocytopenia developed. Allergic changes and liver or renal damage were never observed. The authors suggest introduction of the drug in treatment of epilepsy in view of its favourable clinical effect even in cases refractory to previous treatment, especially since the drug is relatively well tolerated.
Generate a file for use with external citation management software.
Generic Name: clonazepam. Therapy: epilepsy. More Information. The following links will take you to the Medsafe website for further information: Consumers:.
Health Professionals: view the Data Sheet.
Rivotril (clonazepam) injection and oral solution.
Hoffmann-La Roche Ltd. Privacy statement Legal Statement 2012 F.
Access to this site is subject to the terms in our legal statement; You accept these terms by continuing to access this site. This website was last updated on 1 May 2015. 2015 Roche Products (New Zealand) Ltd and Roche Diagnostics NZ Limited. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. ID545/TAPSNA4198/2010JUN. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.
Skip to content.
Consumers: view the Consumer Medicine Information (CMI).
Generic Name: clonazepam Therapy: epilepsy More Information.
The following links will take you to the Medsafe website for further information:
Rivotril. (clonazépam). Fiche d'information : Comment ce médicament agit-il ? Quels sont ses effets ? Comment doit-on employer ce médicament ? Sous quelles.